Delayed
Hong Kong S.E.
04:08:20 2024-05-14 am EDT
|
5-day change
|
1st Jan Change
|
1.85
HKD
|
-0.54%
|
|
-4.15%
|
+59.48%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
2,964
|
1,964
|
1,755
|
2,424
|
2,473
|
1,471
|
Enterprise Value (EV)
1 |
4,913
|
4,033
|
4,750
|
5,691
|
7,938
|
11,605
|
P/E ratio
|
3.71
x
|
4.25
x
|
3.17
x
|
2.14
x
|
6.42
x
|
-4.72
x
|
Yield
|
7.69%
|
10.6%
|
15.2%
|
17.6%
|
7.25%
|
-
|
Capitalization / Revenue
|
0.33
x
|
0.2
x
|
0.19
x
|
0.29
x
|
0.26
x
|
0.17
x
|
EV / Revenue
|
0.55
x
|
0.42
x
|
0.52
x
|
0.68
x
|
0.84
x
|
1.32
x
|
EV / EBITDA
|
8.69
x
|
11.2
x
|
3.65
x
|
3.48
x
|
20.4
x
|
-40.3
x
|
EV / FCF
|
-14.9
x
|
-6.49
x
|
-6.63
x
|
16.7
x
|
-5.03
x
|
-2.66
x
|
FCF Yield
|
-6.7%
|
-15.4%
|
-15.1%
|
5.99%
|
-19.9%
|
-37.5%
|
Price to Book
|
0.86
x
|
0.55
x
|
0.44
x
|
0.51
x
|
0.53
x
|
0.34
x
|
Nbr of stocks (in thousands)
|
1,190,000
|
1,190,000
|
1,190,000
|
1,190,000
|
1,190,000
|
1,190,000
|
Reference price
2 |
2.490
|
1.651
|
1.475
|
2.037
|
2.078
|
1.236
|
Announcement Date
|
4/19/18
|
4/15/19
|
4/20/20
|
3/24/21
|
4/11/22
|
4/11/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
8,897
|
9,586
|
9,191
|
8,323
|
9,499
|
8,818
|
EBITDA
1 |
565.6
|
359.4
|
1,300
|
1,635
|
388.7
|
-288
|
EBIT
1 |
16.42
|
-181.4
|
712.1
|
1,068
|
-104.9
|
-811.8
|
Operating Margin
|
0.18%
|
-1.89%
|
7.75%
|
12.83%
|
-1.1%
|
-9.21%
|
Earnings before Tax (EBT)
1 |
743.8
|
389.8
|
658.6
|
1,392
|
442.2
|
-364.5
|
Net income
1 |
690.8
|
398.9
|
550.5
|
1,123
|
380.6
|
-307.9
|
Net margin
|
7.76%
|
4.16%
|
5.99%
|
13.49%
|
4.01%
|
-3.49%
|
EPS
2 |
0.6719
|
0.3887
|
0.4657
|
0.9510
|
0.3236
|
-0.2618
|
Free Cash Flow
1 |
-329.1
|
-621.1
|
-716.5
|
341
|
-1,578
|
-4,356
|
FCF margin
|
-3.7%
|
-6.48%
|
-7.8%
|
4.1%
|
-16.62%
|
-49.4%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
20.85%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
30.36%
|
-
|
-
|
Dividend per Share
2 |
0.1915
|
0.1756
|
0.2235
|
0.3579
|
0.1507
|
-
|
Announcement Date
|
4/19/18
|
4/15/19
|
4/20/20
|
3/24/21
|
4/11/22
|
4/11/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
1,949
|
2,068
|
2,995
|
3,268
|
5,465
|
10,133
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.446
x
|
5.754
x
|
2.304
x
|
1.998
x
|
14.06
x
|
-35.19
x
|
Free Cash Flow
1 |
-329
|
-621
|
-717
|
341
|
-1,578
|
-4,356
|
ROE (net income / shareholders' equity)
|
20%
|
8.47%
|
15.2%
|
27.4%
|
7.89%
|
-7.82%
|
ROA (Net income/ Total Assets)
|
0.11%
|
-1.26%
|
4.51%
|
6.23%
|
-0.52%
|
-3.12%
|
Assets
1 |
617,331
|
-31,748
|
12,218
|
18,034
|
-73,449
|
9,872
|
Book Value Per Share
2 |
2.880
|
3.030
|
3.360
|
3.960
|
3.920
|
3.610
|
Cash Flow per Share
2 |
0.2300
|
0.3800
|
0.5000
|
0.6500
|
0.5000
|
0.1800
|
Capex
1 |
413
|
545
|
206
|
1,949
|
2,463
|
2,611
|
Capex / Sales
|
4.64%
|
5.69%
|
2.24%
|
23.42%
|
25.93%
|
29.61%
|
Announcement Date
|
4/19/18
|
4/15/19
|
4/20/20
|
3/24/21
|
4/11/22
|
4/11/23
|
|
1st Jan change
|
Capi.
|
---|
| +59.48% | 283M | | +5.92% | 105B | | -4.43% | 64.68B | | +60.48% | 43.21B | | +16.73% | 39.33B | | +6.77% | 32.99B | | +12.31% | 20.09B | | +13.41% | 17.05B | | +25.44% | 15.96B | | +5.80% | 14.69B |
Other Commodity Chemicals
|